Q

Quark Venture

5 employees

A Vancouver-based VC firm focused on the biotech and life sciences space

Investor insights

Sectors invested in

Biotechnology22
Health Care16
Pharmaceutical11
Medical9
Therapeutics8
Medical Device7
Biopharma5
Cardiology4
Clinical Trials4
Heart Failure3
Medical Devices3
LAP Regulation3
Life Science3
Biotech3
biotechnology3
pharmaceuticals3
cancer3
bladder cancer3
polymer3
drug delivery3

Funding rounds participated in

$20M sweet spot round size

Most of their 31 investments are in rounds between $8M and $30M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Investment
Partnerships
Health Sciences
Commercialization

Date founded

2016

Investments made

A

Alpha-9 Theranostics Inc. raised $75M on December 14, 2022

Investors: Nextech Invest, Samsara BioCapital, Longitude Capital and Quark Venture

V

V-Wave raised $98M on December 16, 2021

Investors: Pontifax Venture Capital, Triventures, Pura Vida Investments, Aperture Venture Partners, BRM Group, ISF Israel Secondary Fund, Endeavour Vision and Quark Venture

L

Lyndra Therapeutics raised $61M on June 24, 2021

Investors: Gilead Sciences, ImpactAssets, The Invus Group, Polaris Partners, Limitless Ventures, Catalytic Impact Foundation and Quark Venture

V

Volastra Therapeutics raised $32M on April 6, 2021

Investors: Vida Ventures, LLC, ARCH Venture Partners, Catalio Capital Management, Polaris Partners and Quark Venture

U

Undisclosed raised $21M on March 11, 2021

Investors: Valence Life Sciences, Sanderling Ventures and Quark Venture

V

V-Wave raised $28M on September 22, 2020

Investors: Pura Vida Investments, Endeavour Vision, Triventures, BRM Group, Aperture Venture Partners, ISF Israel Secondary Fund, Pontifax Venture Capital and Quark Venture

E

EnClear Therapies raised $10M on February 19, 2020

Investors: Thiel Capital, Dolby Family Ventures, 20/20 HealthCare Partners, Bioverge, Presight Capital and Quark Venture

E

EYEVENSYS raised $30M on January 8, 2020

Investors: Pureos Bioventures, Pontifax Venture Capital, Karista and Quark Venture

U

Undisclosed raised $22M on December 18, 2019

Investors: DOCOR, Pontifax Venture Capital, Catalyst Investments and Quark Venture

U

Undisclosed raised $2M on December 3, 2019

Investors: Peregrine Ventures, Catalyst Investments and Quark Venture

FAQ